| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GNRC | Common Stock | Options Exercise | $990K | +62.1K | +10.33% | $15.94* | 663K | Feb 1, 2022 | Direct | F1 |
| transaction | GNRC | Common Stock | Sale | -$905K | -3.23K | -0.49% | $280.08 | 660K | Feb 1, 2022 | Direct | F1, F2, F3 |
| transaction | GNRC | Common Stock | Sale | -$2.98M | -10.6K | -1.61% | $281.16 | 649K | Feb 1, 2022 | Direct | F1, F2, F4 |
| transaction | GNRC | Common Stock | Sale | -$3.12M | -11.1K | -1.7% | $282.16 | 638K | Feb 1, 2022 | Direct | F1, F2, F5 |
| transaction | GNRC | Common Stock | Sale | -$620K | -2.19K | -0.34% | $282.96 | 636K | Feb 1, 2022 | Direct | F1, F2, F6 |
| transaction | GNRC | Common Stock | Sale | -$796K | -2.8K | -0.44% | $284.05 | 633K | Feb 1, 2022 | Direct | F1, F2, F7 |
| transaction | GNRC | Common Stock | Sale | -$1.43M | -5K | -0.79% | $286.29 | 628K | Feb 1, 2022 | Direct | F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GNRC | Stock Option (Right to Buy) | Options Exercise | $0 | -62.1K | -100% | $0.00* | 0 | Feb 1, 2022 | Common Stock | 62.1K | $15.94 | Direct | F1, F9 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were automatically effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 8, 2021 and established by the reporting person for the purpose of an orderly sale of shares related to the exercise of options scheduled to expire in February 2022. |
| F2 | The shares of common stock were sold solely to satisfy the reporting person's exercise price and tax withholding obligations related to the exercise of stock options to purchase 62,087 shares as reported herein, with the reporting person retaining the remaining shares. |
| F3 | The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $279.64 to $280.60, inclusive. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and prices at which the shares were sold. |
| F4 | The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $280.65 to $281.62, inclusive. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and prices at which the shares were sold. |
| F5 | The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $281.65 to $282.64, inclusive. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and prices at which the shares were sold. |
| F6 | The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $282.65 to $283.33, inclusive. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and prices at which the shares were sold. |
| F7 | The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $283.66 to $284.44, inclusive. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and prices at which the shares were sold. |
| F8 | These shares were sold pursuant to the terms of a trading plan under Rule 10b5-1, previously entered into on November 8, 2021. |
| F9 | Subject to continued service through the vesting date, the Options vested in equal installments on each of the first four (4) anniversaries of the Date of Grant. |